References
Series 3
The perinatal disposition of thiopentone. Wolf, L.; Morgan, D.J.; Blackman, G.L. et al.: Clinical and Experimental Pharmacology and Physiology 7: 680 (1980).
The pharmacokinetics of midazolam in man. Smith, M.T.; Eadie, M.J.; O’Rourke-Brophy, T. et al.: Clinical and Experimental Pharmacology and Physiology 7: 680 (1980).
Steady-state bioavailability of a slow release theophylline formulation in children with acute asthma. Birkett, D.J.; Coulthard, K.; Miners, J.O. et al.: Clinical and Experimental Pharmacology and Physiology 7: 682 (1980).
Clinical pharmacokinetics of the non-depolarising muscle relaxants. Ramzan, M.I.; Somogyi, A.A.; Walker, J.S. et al.: Clinical Pharmacokinetics 6: 25–60 (1981).
Pharmacokinetics in intravenous anaesthetic practice. Duvaldestin, P.: Clinical Pharmacokinetics 6: 61–82 (1981).
Rapid estimation of chloramphenicol clearance in infants and children. Koup, J.R.; Sack, C.M.; Smith, A.L. et al.: Clinical Pharmacokinetics 6: 83–88 (1981).
The effect of age on the pharmacokinetics of diazepam. Macklon, A.F.; Barton, M.; James, O. et al.: Clinical Science 59: 479–483 (1980).
Aging and renal clearance of procainamide and acetylprocainamide. Reidenberg, M.M.; Camacho, M.; Kluger, J. et al.: Clinical Pharmacology and Therapeutics 28; 732 (1980).
Hydralazine kinetics in hypertensive patients after intravenous administration. Ludden, T.M.; Shepherd, A.M.M.; McNay, J.L. et al.: Clinical Pharmacology and Therapeutics 28: 736 (1980).
Kinetic and clinical observations ixknotic children on propranolol therapy. Riopel, D.A.; Walle, T. et al.: Clinical Pharmacology and Therapeutics 28: 743 (1980).
Influence of surgery on plasma propranolol levels and protein binding. Feely, J.; Forrest, A.; Gunn, A. et al.: Clinical Pharmacology and Therapeutics 28: 759 (1980).
Factors influencing nortriptyline steady-state kinetics: Plasma and saliva levels. Kragh-Sørenson, P.; Larsen, N.E. et al.: Clinical Pharmacology and Therapeutics 28: 796 (1980).
Verapamil protein binding in patients and normal subjects. Keefe, D.L.; Yee, Y-G.; Kates, R.E. et al.: Clinical Pharmacology and Therapeutics 29: 21 (1981).
Verapamil disposition in liver disease and intensive-care patients: Kinetics, clearance and apparent blood flow relationships. Woodcock, B.G.; Rietbrock, I.; Vohringer, H.F. et al.: Clinical Pharmacology and Therapeutics 29: 27 (1981).
Kinetics of single doses of fenbufen in patients with renal insufficiency. Rogers, H.J.; Savitsky, J.P.; Glenn, B. et al.: Clinical Pharmacology and Therapeutics 29: 74 (1981).
Effect of cardiopulmonary bypass on fentanyl distribution and elimination. Koska, A.J. III.; Romagnoli, A.; Kramer, W.G.: Clinical Pharmacology and Therapeutics 29: 100 (1981).
Cimetidine clearance and bioavailability in hepatic cirrhosis. Sonne, J.; Poulsen, M.E.; Døssing, M. et al.: Clinical Pharmacology and Therapeutics 29: 191 (1981).
Phenytoin binding to partially purified albumin in renal disease. Kinniburgh, D.W.; Boyd, N.D.: Clinical Pharmacology and Therapeutics 29: 203 (1981).
Acetaminophen kinetics in obesity. Abernethy, D.R.; Divoll, M.; Ameer, B. et al.: Clinical Pharmacology and Therapeutics 29: 230 (1981).
Desmethyl diazepam kinetics in obesity. Abernethy, D.R.; Greenblatt, D.J.; Divoll, M.: Clinical Pharmacology and Therapeutics 29: 231 (1981).
Pharmacokinetics of betaxolol in hypertensive children. Assael, B.M.; Palminteri, R.; Bianchetti, G. et al.: Clinical Pharmacology and Therapeutics 29: 232 (1981).
Elimination kinetics of moxalactam in patients with renal impairment. Aronoff, G.R.; Sloan, R.S.; Luft, F.C.: Clinical Pharmacology and Therapeutics 29: 232 (1981).
Placental transfer and pharmacokinetics of acebutolol in newborn infants. Bianchetti, G.; Cubruc, C.; Vert, P. et al.: Clinical Pharmacology and Therapeutics 29: 233 (1981).
Disopyramide pharmacokinetics in normal and end-stage renal failure subjects. Blair, A.D.; Burgess, E.D.; Cutler, R.E.: Clinical Pharmacology and Therapeutics 29: 234 (1981).
Pharmacokinetic profile of vitamin E in premature neonates following a single intramuscular injection. Colburn, W.A.; Ehrenkranz, R.A.: Clinical Pharmacology and Therapeutics 29: 237 (1981).
Pharmacokinetic consequences of variations in plasma propranolol binding due to rheumatoid arthritis. DeLeve, L.D.; Piafsky, K.M.: Clinical Pharmacology and Therapeutics 29: 239 (1981).
Concentrations of tolmetin and its metabolite in serum and synovial fluid of rheumatoid arthritic patients. Desiraju, R.K.; Nayak, R.K.; Sedberry, D.C. et al.: Clinical Pharmacology and Therapeutics 29: 240 (1981).
Nadolol excretion in human milk. Devlin, R.G.; Fleiss, P.M.: Clinical Pharmacology and Therapeutics 29: 240 (1981).
Chronic obstructive lung disease and sulfamethazine protein binding, du Souich, P.; Desjardins, R.; Amyot, R. et al.: Clinical Pharmacology and Therapeutics 29: 242 (1981).
Pharmacokinetic determinants in the treatment of alcoholic liver disease with propylthiouracil. Giles, H.G.; Roberts, E.A.; Orrego, H. et al.: Clinical Pharmacology and Therapeutics 29: 248 (1981).
Desalkylflurazepam kinetics in the elderly following single and multiple doses of flurazepam (Dalmane). Greenblatt, D.J.; Divoll, M.; Harmatz, J.S. et al.: Clinical Pharmacology and Therapeutics 29: 249 (1981).
Antipyrine kinetics in the elderly: Prediction of benzodiazepine oxidizing capacity. Greenblatt, D.J.; Divoll, M.; Abernethy, D.R. et al.: Clinical Pharmacology and Therapeutics 29: 249 (1981).
The volume of distribution of lidocaine in chronic hepatitis: Relationship with serum a1-glycoprotein and serum protein binding. Huet, P.M.; Arsene, D.; Richer, G.: Clinical Pharmacology and Therapeutics 29: 252 (1981).
Pharmacokinetic study of valproic acid in a neonate. Irvine-Meek, J.M.; Hall, K.W.; Otten, N.H. et al.: Clinical Pharmacology and Therapeutics 29: 253 (1981).
Age-related changes in the disposition of aminopterin in cancer patients. Israili, Z.H.; York, R.M.; Moore, M. et al.: Clinical Pharmacology and Therapeutics 29: 254 (1981).
A computer program for adaptive control of gentamicin dosage in newborn infants. Jelliffe, R.W.; Bernard, B.; Garcia-Cazares, S. et al.: Clinical Pharmacology and Therapeutics 29: 255 (1981).
Disposition kinetics of verapamil and norverapamil. Kates, R.E.; Keefe, D.; Schwartz, J. et al.: Clinical Pharmacology and Therapeutics 29: 257 (1981).
Altered disposition of carprofen and indomethacin in rheumatoid arthritis. Kelly, J.F.; Upton, R.A.; Lin, E.T. et al.: Clinical Pharmacology and Therapeutics 29: 257 (1981).
Pharmacokinetics of N-acetylprocainamide in subjects with cardiomyopathy. Ludden, T.M.; Crawford, M.H.: Clinical Pharmacology and Therapeutics 29: 262 (1981).
Dose-independent hydralazine pharmacokinetics after intravenous administration to hypertensive patients. Ludden, T.M.; Shepherd, A.M.M.; McNay, J.L. et al.: Clinical Pharmacology and Therapeutics 29: 262 (1981).
Hemodialysis clearance of ethosuximide in end-stage renal failure patients. Marbury, T.C.; Lee, C.S.; Perchalski, R.J. et al.: Clinical Pharmacology and Therapeutics 29: 264 (1981).
Alprozolam kinetics in the elderly: Relation to antipyrine disposition. Moschitto, L.J.; Greenblatt, D.J.; Divoll, M. et al.: Clinical Pharmacology and Therapeutics 29: 267 (1981).
Diazepam kinetics in chronic renal failure. Ochs, H.R.; Greenblatt, D.J.; Abernethy, D.R. et al.: Clinical Pharmacology and Therapeutics 29: 270 (1981).
Cimetidine disposition in continuous ambulatory peritoneal dialysis. Paton, T.W.; Manuel, M.A.; Walker, S.E.: Clinical Pharmacology and Therapeutics 29: 271 (1981).
Dependence of neonatal drug binding on a1-acid glycoprotein concentration. Piafsky, K.M.; Mpamugo, L.: Clinical Pharmacology and Therapeutics 29: 272 (1981).
Therapeutic monitoring of lidocaine concentrations. Stargel, W.W.; Shand, D.G., Wagner, G.S. et al.: Clinical Pharmacology and Therapeutics 29: 284 (1981).
Liver and drug metabolism in chronic alcoholics. Sotaniemi, E.A.; Pelkonen, O.; Oilinki, O.: Clinical Pharmacology and Therapeutics 29: 284 (1981).
Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis. Sevka, M.J.; Matthews, S.J.; Nightingale, C.H. et al.: Clinical Pharmacology and Therapeutics 29: 322 (1981).
Clearance and recovery calculations in hemodialysis: Application to plasma, red blood cell, and dialysate measurements for cyclophosphamide. Wang, L.H.; Lee, C.S.; Majeske, B.L. et al.: Clinical Pharmacology and Therapeutics 29: 365 (1981).
Heparin kinetics: Variables related to disposition and dosage. Cipolle, R.J.; Seifert, R.D.; Neilan, B.A. et al.: Clinical Pharmacology and Therapeutics 29: 387 (1981).
Primidone kinetics: Effects of concurrent drugs and duration of therapy. Cloyd, J.C.; Miller, K.W.; Leppik, I.E.: Clinical Pharmacology and Therapeutics 29: 402 (1981).
Multi-centre study of acebutolol in hypertensive subjects: Results for patients from the 50–64 years’ old and over 65 years’ old age groups. Guerin, A.; Baker, P.G.; Goulton, J.: Current Medical Research and Opinion 7: 179 (1981).
Initial evaluation of kinetics and efficacy of moxalactam (LY0127935) in neonatal systemic gram-negative bacterial disease. McKee, K.T. Jr.; Wright, P.F.; Gregg, C.R. et al.: Current Therapeutic Research 28: 603 (1980).
Percutaneous absorption of hydroxyurea through psoriatic lesions. Shrewsbury, R.P.; Foster, T.S.; Dittert, L.W. et al.: Current Therapeutic Research 28: 1002 (1980).
Treatment of purulent meningitis in adults with injectable amoxycillin: clinical and pharmacokinetic results. Lecut, J.Y.; Humbert, G.; Aubertin, J. et al.: Current Therapeutic Research 29: 36 (1981).
Series 4
Cabamazepine: Influence of drug regimen on plasma concentrations during monotherapy. Zagnoni, P.; DeBernardi, M.; Canger, R. et al.: Acta Neurologica Scandinavica 62: 64 (1980).
Half life in plasma of intramuscular sulprostone for termination of second trimester pregnancy. Lippert, T.H. and Briel, R.C.: Acta Therapeutica 6: 42 (1980).
Plasma 25-hydroxyvitamin D concentrations in preterm infants receiving oral vitamin B supplements. Robinson, M.J.; Merrett, A.L.; Tetlow, V.A. et al.: Archives of Diseases in Childhood 56: 144 (1981).
Studies on blood concentrations after spinal and extradural administration of morphine for the treatment of chronic and acute pain. Dick, W.; Kossman, B.; Driessen, A.: British Journal of Anaesthesia 53: 118 (1981).
Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people. Collart, P.; Poitevin, M.; Milovanovic, A. et al.: British Journal of Venereal Diseases 56: 355 (1980).
Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes. Salimtschik, M.; Mouridsen, H.T.; Loeber, J. et al.: Cancer Chemotherapy and Pharmacology 4: 267 (1980).
Clinical pharmacokinetics of calcium ion antagonists. Eichelbaum, M.: Clinical and Investigative Medicine 3: 13 (1980).
Transfer of cyproterone acetate to the milk of lactating women. Stoppelii, I.; Rainer, E. and Humpel, M.: Contraception 22: 485 (1980).
A pharmacological study of cefaclor in the newborn infant. Chin. K.C.; Kerr, M.M.; Cockburn, F. et al.: Current Medical Research and Opinion 7: 168 (1981).
Interindividual variation and drug interactions with hormonal steroid contraceptives. Back, D.J.; Breckenridge, A.M.; Crawford, F.E. et al.: Drugs 21: 46–61 (1981).
Digitalis levels. Berdeaux, A.; Giudicelli, J.F.: Gazette Medicale de France 87: 4705 (1980).
Pharmacokinetics of amitriptyline in the elderly. Henry, J.F.; Altamura, C.; Gomeni, R. et al.: International Journal of Clinical Pharmacology Therapy and Toxicology 19: 1 (1981).
Pharmacodynamic aspects of long-term prophylactic lithium. Birch, N.J.; Greenfield, A.A. and Hullin, R.P.: International Pharmacopsychiatry 15: 91 (1980).
Serum and hydatid cystic fluid levels of mebendazole in patients with liver hydratidosis. Brandimarte, C.; Attili, A.F.; Cantafora, A. et al.: Italian J. Gastroenterol. 12: 212 (1980).
Pharmacokinetics of sodium valproate in epileptic patients after an intravenous bolus administration. Mehta, A.C.; Calvert, R.T.; Rigby, J. et al.: Journal of Clinical and Hospital Pharmacy 5: 329 (1980).
A prospective randomised trial on the effect of monitoring plasma anticonvulsants levels in epilepsy. Froscher, W.; Eichelbaum, M.; Gugler, R. et al.: Journal of Neurology 224: 193 (1981).
Problems of the therapy with glycosides in chronic renal failure and uremia. Rupp, M.: Brass, H.; Glockler, D.: Die Medizinische Welt 32: 115 (1981).
Problems in drug therapy of children — interaction pharmacokinetics in relation to age — recommendation for dosage. Gladtke, E.: Die Medizinische Welt 32: 219 (1981).
Acute changes in the renin-angiotensin-aldosterone system, catecholamines and prostaglandins during captopril in man. Lijnen, P.; Verschureren, L.J.; Fagard, R. et al.: Methods and Findings in Experimental and Clinical Pharmacology 2: 293 (1980).
Use of antibacterial drugs in pregnancy. Reinlein, J.M.A.; Garcia, F.S.: Minerva Medica 71: 2951–2957 (1980).
Phenobarbital serum levels in premature and newborn infants. Erttman, R.; Hellwege, H.H.; Lagenstein, I.: Naunyn Schmiedeberg’s Archives of Pharmacology 313: 54 (1980).
Inhibition of digoxine absorption in chronic uremia. Wizemann, V.; Birk, H.W.: Nauny Schmiedeberg’s Archives of Pharmacology 313: 55 (1980).
On the way to effective plasma concentrations (PC) of merendazole (M) in the treatment of alveolar echinococcosis. Witassek, F.; Burkhardt, B.; Eckert, J. et al.: Naunyn Schmiedeberg’s Archives of Pharmacology 313: 62 (1980).
Plasma profiles of two differing doses of fenoprofen in geriatric patients. Kamal, A.; Koch, I.M.: Pharmatherapeutica 2: 552 (1981).
Renal side effects of lithium. The importance of the serum lithium level. Vestergaard, P.; Thomsen, K.: Psychopharmacology 72: 203 (1981).
Use of liver function tests as predictors of rifampicin metabolism in cirrhosis. McConnell, J.B.; Powell-Jackson, P.R.; Davis, M. et al.: Quarterly Journal of Medicine 74: 77 (1981).
Serum levels of mecillinam in patients with severely impaired renal function. Svarva, P.L.; Wessel-Aas, T.: Scandinavian Journal of Infectious Diseases 12: 303 (1980).
Study of penetration of cefuroxime into bronchial secretions and of its placental transfer. Bergogne-Berezin, E.; Pierre, J.; Even, P. et al.: Therapie 35: 677 (1980).
Rights and permissions
About this article
Cite this article
Current Literature References on Clinical Pharmacokinetics. Clin Pharmacokinet 6, 326–328 (1981). https://doi.org/10.2165/00003088-198106040-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198106040-00007